TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
INGN

Inogen Inc

Healthcare · Medical Devices

5.30$ -1.9% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Income Statement

Inogen Inc (INGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 95 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement INGN
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
54 51 53 64 69 64 79 97 95 87 90 101 92 79 88 72 74 74 87 102 93 76 80 103 105 88 72 84 84 76 78 89 89 80 82 92 92 82 85 95 354
29 26 27 33 36 33 41 49 46 43 46 51 48 45 50 39 41 40 47 51 45 38 45 57 63 59 41 50 50 48 44 46 47 44 46 51 45 41 43 52 181
25 25 26 32 33 31 38 48 49 44 44 50 43 34 38 33 33 34 40 50 48 39 35 46 43 29 31 34 34 28 34 43 41 36 36 41 47 41 42 43 173
1.4 1.2 1.3 1.3 1.4 1.4 1.4 1.8 2.1 1.7 1.7 1.5 2.6 3.6 3.6 3.3 3.5 3.7 4.0 4.1 3.8 4.7 5.4 6.1 4.6 5.9 5.3 4.3 4.5 6.7 6.6 5.6 3.5 5.9 4.0 5.2 4.8 5.3 5.1 5.9 21
8.7 8.0 8.3 9.9 10 9.0 9.6 9.7 10.0 8.8 9.7 8.8 8.5 10 9.8 9.7 8.6 11 12 5.2 9.3 11 15 13 15 1.3 19 15 17 25 17 19 19 18 16 17 18 16 17 18 69
20 19 20 23 25 26 29 34 38 39 40 38 35 39 41 35 35 40 42 39 41 45 49 49 53 88 53 46 80 57 51 50 49 48 44 47 54 51 50 48 203
5.4 6.2 5.6 8.5 8.3 5.2 8.7 14 10 4.8 4.9 12 8.1 -5.3 -2.2 -2.4 -2.0 -5.5 -2.1 12 6.4 -6.7 -14 -2.9 -10 -58 -22 -12 -47 -29 -16 -7.1 -7.8 -11 -7.7 -6.1 -7.1 -9.3 -8.4 -5.1 -30
0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.9 1.5 1.2 1.5 0.6 1.1 0.6 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.9 1.7 1.8 – – 1.8 – – – – – – – – – – –
5.4 5.8 5.9 9.2 8.8 5.8 9.7 14 11 5.8 6.1 14 8.8 -4.2 -1.7 3.5 -1.9 -5.2 -2.4 12 5.9 -6.9 -14 -3.4 -9.4 -56 -20 -9.8 -45 -27 -15 -5.6 -6.1 -10 -6.3 -4.3 -5.4 -7.4 -8.5 -4.0 -25
2.0 0.6 -0.1 0.8 1.5 6.4 -1.1 -1.0 -5.1 -4.2 0.8 3.5 1.9 -2.9 -0.1 0.9 -0.2 -0.1 -1.7 6.9 -6.2 16 0.2 0.1 0.1 0.1 0.2 0.0 0.4 -0.5 -0.2 0.0 -0.1 -0.3 -0.1 -0.2 -0.1 -0.2 -0.2 -0.2 -0.7
3.5 5.3 5.9 8.3 7.3 -0.6 11 15 16 10 5.3 10 6.9 -1.4 -1.6 2.6 -1.7 -5.1 -0.7 5.1 12 -23 -14 -3.4 -9.5 -57 -20 -9.8 -46 -27 -15 -5.6 -6.0 -9.8 -6.2 -4.2 -5.3 -7.1 -8.3 -3.9 -25
8.9 9.4 9.1 12 12 9.3 12 17 13 7.5 8.9 15 12 -0.7 2.3 2.1 2.7 -0.6 3.0 17 11 -1.1 -8.2 2.5 -3.5 -0.4 -16 -5.5 -9.2 -22 -9.5 -0.3 -0.8 -5.0 -1.1 0.9 -0.2 -2.3 -3.6 -0.6 -6.7

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?